ethyl pyruvate has been researched along with Mesothelioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchi, ME; Carbone, M; Forest, KH; Gaudino, G; Jube, S; Larson, D; Morris, P; Napolitano, A; Negi, VS; Pagano, I; Pass, HI; Pastorino, S; Pellegrini, L; Saad-Jube, ZS; Xue, J; Yang, H | 1 |
1 other study(ies) available for ethyl pyruvate and Mesothelioma
Article | Year |
---|---|
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neoplasm Staging; Prognosis; Pyruvates; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |